Hospital
Baptist Medical Center-Leake INC
Baptist Medical Center-Leake INC was paid $8.26M by Medicaid between Jan 2018 and Dec 2024, across 116 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.
33Billing provider infoBAPTIST MEDICAL CENTER-LEAKE INC
CARTHAGE, MS 39051
CARTHAGE, MS 39051
33aNPI1205112539assigned 11/01/2011
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$8.26M
24GClaims233,204
24DCodes billed116
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DUCKETT, GREGORY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,667 | $1.16M | |
| 2019 | 32,282 | $1.24M | |
| 2020 | 25,824 | $949K | |
| 2021 | 34,046 | $1.20M | |
| 2022 | 53,813 | $1.43M | |
| 2023 | 34,034 | $1.26M | |
| 2024incomplete | 23,538 | $1.02M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 19% | 15,131 | 11,831 | $1.56M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 9,557 | 7,346 | $1.33M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 5,274 | 4,145 | $949K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.1% | 5,926 | 4,795 | $424K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 4.7% | 4,824 | 927 | $391K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.2% | 4,536 | 3,493 | $350K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.9% | 6,946 | 5,045 | $242K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.6% | 5,033 | 4,165 | $215K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.6% | 2,855 | 2,288 | $213K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.6% | 6,470 | 5,055 | $212K |
| 71045 | Radiologic examination, chest; single view | 2.4% | 5,918 | 4,472 | $202K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.2% | 879 | 699 | $178K |
104 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.0% | 2,246 | $168K |
| 71046 | Radiologic examination, chest; 2 views | 1.9% | 3,652 | $160K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.9% | 1,873 | $154K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.6% | 2,218 | $135K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.6% | 10,598 | $132K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.6% | 7,280 | $129K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.3% | 722 | $105K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 19,934 | $104K |
| 80053 | Comprehensive metabolic panel | 1.2% | 12,721 | $100K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,183 | $74K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 5,503 | $73K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,357 | $46K |
| 83880 | <1% | 2,398 | $44K | |
| 74018 | <1% | 973 | $44K | |
| G0378 | Hospital observation service, per hour | <1% | 241 | $43K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,691 | $39K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,682 | $35K |
| 84484 | <1% | 5,733 | $34K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 16,414 | $34K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,803 | $28K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,919 | $26K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,481 | $21K |
| 73560 | <1% | 512 | $21K | |
| 80061 | Lipid panel | <1% | 1,738 | $20K |
| 81001 | <1% | 8,435 | $18K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,014 | $14K |
| 81025 | <1% | 2,400 | $14K | |
| 80305 | <1% | 1,316 | $12K | |
| 87807 | <1% | 1,074 | $11K | |
| 73630 | <1% | 273 | $11K | |
| 83690 | <1% | 2,365 | $11K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 26 | $10K |
| 82553 | <1% | 853 | $9K | |
| A9270 | Non-covered item or service | <1% | 2,446 | $7K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 70 | $6K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 38 | $6K |
| 83735 | <1% | 1,770 | $6K | |
| 83605 | <1% | 1,127 | $5K | |
| 73030 | <1% | 129 | $5K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 53 | $5K |
| 82550 | <1% | 925 | $5K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,025 | $5K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 16 | $5K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 70 | $4K |
| 87040 | <1% | 629 | $4K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,102 | $4K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,420 | $4K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 13 | $4K |
| 87186 | <1% | 768 | $3K | |
| 82150 | <1% | 544 | $3K | |
| 73610 | <1% | 66 | $3K | |
| 85379 | <1% | 396 | $3K | |
| 84702 | <1% | 132 | $2K | |
| 85610 | <1% | 987 | $2K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 157 | $2K |
| 87400 | <1% | 86 | $2K | |
| 87210 | <1% | 603 | $2K | |
| 85027 | <1% | 396 | $2K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 200 | $2K |
| 73130 | <1% | 34 | $2K | |
| 86308 | <1% | 209 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 13 | $1K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 25 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,527 | $1K |
| 74019 | <1% | 15 | $1K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 23 | $1K |
| 87430 | <1% | 64 | $936.36 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 44 | $916.36 |
| 96376 | <1% | 69 | $879.97 | |
| 82803 | <1% | 26 | $768.57 | |
| 83874 | <1% | 46 | $599.70 | |
| 73110 | <1% | 13 | $578.32 | |
| 73502 | <1% | 20 | $531.76 | |
| 86900 | <1% | 24 | $525.00 | |
| 87077 | <1% | 92 | $458.31 | |
| 85730 | <1% | 130 | $417.76 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,120 | $342.92 |
| 86850 | <1% | 24 | $233.04 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 21 | $221.39 |
| 86140 | <1% | 94 | $214.45 | |
| 87070 | <1% | 29 | $192.41 | |
| 36600 | <1% | 12 | $174.66 | |
| 86901 | <1% | 24 | $158.70 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 1,394 | $136.86 |
| 87205 | <1% | 28 | $134.53 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 109 | $133.07 |
| 87147 | <1% | 49 | $106.54 | |
| 84550 | <1% | 32 | $103.06 | |
| 80076 | <1% | 18 | $95.55 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 196 | $93.36 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 773 | $87.76 |
| 84703 | <1% | 20 | $71.75 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 225 | $33.55 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 32 | $29.35 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 94 | $20.42 |
| 36416 | <1% | 14 | $16.80 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 220 | $15.96 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 24 | $4.86 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 16 | $3.85 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 36 | $1.13 |
| 93320 | 0% | 26 | $0.00 | |
| 93325 | 0% | 26 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 12 | $0.00 |
| 84145 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDUCKETT, GREGORY (SR VP/ CLO)
Parent organizationBAPTIST MEMORIAL HEALTH CARE CORP.
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.